Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Δ9-THC With and Without Alcohol on Perception and Driving Performance in Healthy Adults
NCT07176208Phase 1Completed
- Sponsor
- Food and Drug Administration
- Start
- Dec 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dronabinol (6 arms), sponsored by Food and Drug Administration. Primary endpoint: Standard Deviation of Lateral Position compared to alcohol alone up to 8 hours. Started Dec 2025; status: completed.
02
Drugs
dronabinol
Beyond the preview
Go deeper on NCT07176208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07176208.